Skip to main content
FMS
NYSE Industrial Applications And Services

Fresenius SE Sells 13.4M FMC Shares at EUR 39.00, Cutting Stake to 20.9%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$22.06
Mkt Cap
$11.62B
52W Low
$20.02
52W High
$26.42
52W Position info
10% above low
Off High info
17% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

FMS is trading near its 52-week low of $20.02 (10% above the low).

Summary

Fresenius SE sold 13.4 million Fresenius Medical Care shares at EUR 39.00 each for EUR 524.3 million, reducing its stake from 25.01% to 20.9% in its second major selldown since August.


Key Events · Ownership and Investor Activity · FMS

  • Fresenius SE Sells 13.4M Shares

    Fresenius SE placed 13,443,240 Fresenius Medical Care shares at EUR 39.00 each via an accelerated bookbuild run by BNP Paribas, BofA, Deutsche Bank and J.P. Morgan.

  • EUR 524.3M Gross Proceeds

    Gross placement proceeds total EUR 524,286,360.00; the seller receives the net amount after an undisclosed base fee to the joint bookrunners.

  • Stake Cut to 20.9%

    Fresenius SE's holding falls from 67,181,358 shares (25.01%) to 53,738,118 shares (20.9%) of the 257,312,593 shares outstanding as of November 6, 2026.

  • 90-Day Lock-Up Through Mid-February

    Fresenius SE agreed not to sell further shares for 90 days from November 12, 2026 without consent of at least two joint bookrunners, with carve-outs for buybacks and exchange bond deliveries.


Analysis · FMS · Industrial Applications And Services

The parent is steadily loosening its grip on its dialysis subsidiary. Fresenius SE is offloading another 13.4 million Fresenius Medical Care shares — about 5.2% of the company — at EUR 39.00 each for EUR 524.3 million gross, dropping its stake from 25.01% to 20.9%. That makes this the second large selldown in under three months, following the August 2026 sale of 7.8 million shares at EUR 39.56. The overhang is real: a 90-day lock-up now constrains further sales until mid-February 2027, but the direction of travel is clear. Note the pricing — EUR 39.00 versus the prior deal's EUR 39.56, a modest step down that suggests demand required a slightly wider discount this time.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FMS was trading at $22.06 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $20.02 to $26.42. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FMS - Latest Insights

FMS
Nov 03, 2026, 8:04 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $23.02
Real-time Price: $22.07 info
Change: -$0.955 (-4%) info
Market Cap: $11.62B info
FMS
Oct 07, 2026, 12:03 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $20.89
Real-time Price: $22.07 info
Change: +$1.18 (+6%) info
Market Cap: $11.62B info
FMS
Sep 29, 2026, 11:01 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $22.12
Real-time Price: $22.07 info
Change: -$0.050 (-0.23%) info
Market Cap: $11.62B info
FMS
Sep 25, 2026, 7:54 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $22.42
Real-time Price: $22.07 info
Change: -$0.355 (-2%) info
Market Cap: $11.62B info
FMS
Aug 27, 2026, 8:14 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $23.27
Real-time Price: $22.07 info
Change: -$1.20 (-5%) info
Market Cap: $11.62B info